Literature DB >> 8348217

Erectile dysfunction in men under 40: etiology and treatment choice.

C F Donatucci1, T F Lue.   

Abstract

We undertook a retrospective review of 100 impotent men under age 40 to determine the underlying etiologic factors in the group and to evaluate the role of surgery in their care. Although patients ranged in age from 18 to 40 (mean--32.2 years), the number of patients increased steadily with advancing years. The majority of patients (72) had vasculogenic impotence (arteriogenic--15, venogenic--46, mixed--11), followed by psychogenic (13), neurogenic (12) and other causes (4). The differential diagnosis did not correlate with age. Contributing factors were present in 76%, trauma and substance abuse being most common. Essentially equal numbers of patients were treated surgically (40) and with intracavernous injection of vasoactive agents (39). Considerably fewer had a vacuum constriction device (5), oral medication (5), psychotherapy (4), other therapy (4), and none (3). The majority of patients referred to our tertiary urologic practice for treatment of vasculogenic impotence were sent by other urologists. Although the referral source did not appear to influence the choice of treatment, it probably has accounted for the preponderance of vasculogenic impotence in this series.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8348217

Source DB:  PubMed          Journal:  Int J Impot Res        ISSN: 0955-9930            Impact factor:   2.896


  9 in total

Review 1.  Laparoscopic treatment of pudendal nerve and artery entrapment improves erectile dysfunction in healthy young males.

Authors:  Fouad Aoun; Georges Mjaess; Karim Daher; Ghazi Sakr; Anthony Kallas Chemaly; Mohammad Salameh; Simone Albisinni; Fabienne Absil; Thierry Roumeguere; Renaud Bollens
Journal:  Int J Impot Res       Date:  2020-05-04       Impact factor: 2.896

Review 2.  Economic cost of male erectile dysfunction using a decision analytic model: for a hypothetical managed-care plan of 100,000 members.

Authors:  H L Tan
Journal:  Pharmacoeconomics       Date:  2000-01       Impact factor: 4.981

3.  Sexual Adverse Effects and Erectile Dysfunction During Buprenorphine/Naloxone Combination Treatment for Opioid Use Disorders.

Authors:  Engin Emrem Bestepe; Nazlı Tunali; Gökçe Elif Sarıdoğan
Journal:  Neuropsychiatr Dis Treat       Date:  2020-11-12       Impact factor: 2.570

Review 4.  Evaluation of young men with organic erectile dysfunction.

Authors:  Dimitri Papagiannopoulos; Narenda Khare; Ajay Nehra
Journal:  Asian J Androl       Date:  2015 Jan-Feb       Impact factor: 3.285

Review 5.  Aging related erectile dysfunction-potential mechanism to halt or delay its onset.

Authors:  Monica G Ferrini; Nestor F Gonzalez-Cadavid; Jacob Rajfer
Journal:  Transl Androl Urol       Date:  2017-02

6.  Safety and efficacy of daily Revactin® in men with erectile dysfunction: a 3-month pilot study.

Authors:  Sabine Nguyen; Jacob Rajfer; Magda Shaheen
Journal:  Transl Androl Urol       Date:  2018-04

7.  Successful management of cavernosal artery pseudoaneurysm using microcoil embolization.

Authors:  John M Masterson; Luis F Savio; Kenneth Softness; Thomas A Masterson; Jesus Beltran Perez; Shivank Bhatia; Ranjith Ramasamy
Journal:  Transl Androl Urol       Date:  2017-10

Review 8.  Psychological Factors Related to Impotence as a Sexual Dysfunction in Young Men: A Literature Scan for Noteworthy Research Frameworks.

Authors:  Valentina Ciaccio; Dina Di Giacomo
Journal:  Clin Pract       Date:  2022-07-06

Review 9.  Endothelial Dysfunction, Erectile Deficit and Cardiovascular Disease: An Overview of the Pathogenetic Links.

Authors:  Federico De Leonardis; Gaia Colalillo; Enrico Finazzi Agrò; Roberto Miano; Andrea Fuschi; Anastasios D Asimakopoulos
Journal:  Biomedicines       Date:  2022-08-01
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.